Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-03417-1.pdf
Reference75 articles.
1. Januar, V., Saffery, R. & Ryan, J. Epigenetics and depressive disorders: a review of current progress and future directions. Int J Epidemiol 44, 1364–1387, doi: 10.1093/ije/dyu273 (2015).
2. Elgin, S. C. Heterochromatin and gene regulation in Drosophila. Curr Opin Genet Dev 6, 193–202 (1996).
3. Gryder, B. E., Sodji, Q. H. & Oyelere, A. K. Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed. Future Med Chem 4, 505–524, doi: 10.4155/Fmc.12.3 (2012).
4. Hubbert, C. et al. HDAC6 is a microtubule-associated deacetylase. Nature 417, 455–458, doi: 10.1038/417455a (2002).
5. Consalvi, S. et al. Histone Deacetylase Inhibitors in the Treatment of Muscular Dystrophies: Epigenetic Drugs for Genetic Diseases. Mol Med 17, 457–465, doi: 10.2119/molmed.2011.00049 (2011).
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Machine Learning Approaches to Predict the Selectivity of Compounds against HDAC1 and HDAC6;Journal of Computational Biophysics and Chemistry;2024-06-10
2. The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods;Pharmaceuticals;2024-05-10
3. Quantum Chemistry in Drug Design: Density Function Theory (DFT) and Other Quantum Mechanics (QM)-related Approaches;Applied Computer-Aided Drug Design: Models and Methods;2023-12-07
4. Exploring the pharmacokinetic properties and inhibitory potentials of plant-derived alkaloids against nuclear protein targets in triple-negative breast cancer: An In Silico approach;Scientific African;2023-11
5. Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer;European Journal of Medicinal Chemistry;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3